Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Leukemia Research
|
May 31, 2014
TRUE gene silencing for hematologic malignancies
Velizar Shivarov
British Journal of Haematology
|
July 25, 2017
Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data
Velizar Shivarov, Milena Ivanova
Experimental Hematology
|
April 22, 2014
Expression profiling of leukemia patients: key lessons and future directions
Velizar Shivarov, Lars Bullinger
International Journal of Immunogenetics
|
October 28, 2020
HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started
Milena Ivanova, Velizar Shivarov
International Journal of Immunogenetics
|
June 10, 2020
Clonal haematopoiesis and COVID-19: A possible deadly liaison
Velizar Shivarov, Milena Ivanova
British Journal of Haematology
|
May 19, 2020
Clinical outcomes of composite and sequential B-cell lymphomas with features intermediate between DLBCL/PMBCL and classical Hodgkin Lymphoma from the SEER database
Velizar Shivarov, Milena Ivanova
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|
April 26, 2021
Bringing Together the Power of T Cell Receptor Mimic and Bispecific Antibodies for Cancer Immunotherapy: Still a Long Way to Go
Velizar Shivarov, Georgi Blazhev
HLA
|
June 26, 2024
Characterisation of novel MICB alleles by next generation sequencing: MICB*055 and MICB*005:15
Velizar Shivarov, Milena Ivanova
British Journal of Haematology
|
April 13, 2022
Dynamic trends in life expectancy and life years lost over five decades in patients from the SEER database with chronic myeloid leukaemia
Velizar Shivarov, Denitsa Grigorova
HLA
|
June 26, 2024
Characterisation of the novel MICA*112:02 allele by next generation sequencing
Milena Ivanova, Velizar Shivarov
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Leukemia Research
|
May 31, 2014
TRUE gene silencing for hematologic malignancies
Velizar Shivarov
British Journal of Haematology
|
July 25, 2017
Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data
Velizar Shivarov, Milena Ivanova
Experimental Hematology
|
April 22, 2014
Expression profiling of leukemia patients: key lessons and future directions
Velizar Shivarov, Lars Bullinger
International Journal of Immunogenetics
|
October 28, 2020
HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started
Milena Ivanova, Velizar Shivarov
International Journal of Immunogenetics
|
June 10, 2020
Clonal haematopoiesis and COVID-19: A possible deadly liaison
Velizar Shivarov, Milena Ivanova
British Journal of Haematology
|
May 19, 2020
Clinical outcomes of composite and sequential B-cell lymphomas with features intermediate between DLBCL/PMBCL and classical Hodgkin Lymphoma from the SEER database
Velizar Shivarov, Milena Ivanova
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|
April 26, 2021
Bringing Together the Power of T Cell Receptor Mimic and Bispecific Antibodies for Cancer Immunotherapy: Still a Long Way to Go
Velizar Shivarov, Georgi Blazhev
HLA
|
June 26, 2024
Characterisation of novel MICB alleles by next generation sequencing: MICB*055 and MICB*005:15
Velizar Shivarov, Milena Ivanova
British Journal of Haematology
|
April 13, 2022
Dynamic trends in life expectancy and life years lost over five decades in patients from the SEER database with chronic myeloid leukaemia
Velizar Shivarov, Denitsa Grigorova
HLA
|
June 26, 2024
Characterisation of the novel MICA*112:02 allele by next generation sequencing
Milena Ivanova, Velizar Shivarov
Page
of 7